News

Contego Medical Announces ENTRAP Study Initiation for Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection

Raleigh, NC, (September 12, 2017) -- Contego Medical, LLC announced today the initiation of the ENTRAP Study evaluating usage of its Vanguard IEP® Peripheral Balloon Angioplasty System with Integrated Embolic Protection in patients receiving peripheral angioplasty. First cases with the device were performed by Ralf Langhoff, M.D. at Sankt Gertrauden Krankenhaus in Berlin, Germany, with the first enrolled patient treated by Koen Deloose, M.D. at AZ Sint Blasius in Dendermonde, Belgium. The Vanguard IEP System received CE mark in April 2017.

By |September 12th, 2017|News|Comments Off on Contego Medical Announces ENTRAP Study Initiation for Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection

Contego Medical Receives CE Mark for Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection

Raleigh, NC, (April 27, 1017) — Contego Medical, LLC announced today that it has received CE Marking of its Vanguard IEPä Peripheral Balloon Angioplasty System with Integrated Embolic Protection. The Company intends to launch the Vanguard IEP System in Europe to endovascular specialists performing lower limb angioplasty procedures.

By |April 27th, 2017|News|Comments Off on Contego Medical Receives CE Mark for Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection

Contego Medical Completes Enrollment of Paladin Clinical Registry

Raleigh, NC (July 20, 2016) — Contego Medical, LLC announced today that it has completed enrollment in the Paladin® Carotid PostDilation Balloon System Registry in Europe. The registry involved 5 centers with 100 total patients, and represents the first prospective clinical evaluation of a new class of device that provides Integrated Embolic Protection™ (IEP) technology for interventional treatment of carotid stenosis.

By |July 20th, 2016|News|Comments Off on Contego Medical Completes Enrollment of Paladin Clinical Registry

Contego Medical Announces Positive Clinical Data for Paladin System, the First Post-Dilation Balloon with Integrated Embolic Protection Technology

Data presented at the Leipzig Interventional Course (LINC) demonstrates breakthrough treatment for Carotid Artery Disease
Raleigh, NC (January 26, 2016) — Contego Medical, an innovator in developing next generation treatments for coronary and peripheral artery disease, today presented positive post-­market registry data for the Paladin® Carotid Post-­Dilation Balloon with Integrated Embolic Protection™ (IEP) Technology at LINC 2016, in Leipzig, Germany. The presentation included compelling results from a diffusion-­weighted MRI (DW-­MRI) sub-­study that showed improved patient outcomes with the Paladin System.

By |January 26th, 2016|News|Comments Off on Contego Medical Announces Positive Clinical Data for Paladin System, the First Post-Dilation Balloon with Integrated Embolic Protection Technology

Contego Medical Announces European Commercialization of the Paladin® Carotid Post-­Dilation Balloon with Integrated Embolic Protection™ Technology

Presenting at the Leipzig Interventional Course (LINC) from January 26th-­29th in Leipzig, Germany. RALEIGH, NC. (January 14, 2016) – Contego Medical today announced the European commercialization of the Paladin® Carotid Post-­Dilation Balloon, the first and only angioplasty balloon with Integrated Embolic Protection™ (IEP) Technology for patients undergoing carotid stenting procedures. The innovative IEP platform, which combines embolic protection and treatment into one device, is designed to simplify the procedure and improve patient outcomes.

By |January 14th, 2016|News|Comments Off on Contego Medical Announces European Commercialization of the Paladin® Carotid Post-­Dilation Balloon with Integrated Embolic Protection™ Technology

Contego Medical Closes $5.6 Million in Series B Funding

Raleigh, NC (April 17, 2015) – Contego Medical, the first and only provider of the Integrated Embolic ProtectionTM filter platform for angioplasty balloon and stent delivery catheters, announces the completion of a $5.6 million Series B financing round led by Hatteras Venture Partners, an early stage venture firm with a focus on medical devices, biopharmaceuticals, diagnostics and related opportunities in human medicine. The round also included Mountain Group Partners, Lookout Capital and Medical Mutual.

By |April 17th, 2015|News|Comments Off on Contego Medical Closes $5.6 Million in Series B Funding